{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:21:02Z","timestamp":1783974062464,"version":"3.55.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["101007757"],"award-info":[{"award-number":["101007757"]}]},{"name":"European Union\u2019s Horizon 2020"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate clinical and ultrasound (US) features related to psoriatic arthritis (PsA) development in psoriasis (PsO), patients without musculoskeletal (MSK) symptoms and no systemic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective study including PsO patients followed by dermatologists. Clinical and US data were collected at baseline and during follow-up by rheumatologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy-eight patients with PsO were included. Mean disease duration was 15.1 years (SD \u00b1 13.4); most had mild PsO (82%), onychopathy was present in 36 (39.7%) and overweight\/obesity in 38 patients (48.7%). In the US evaluation, nine patients (11.5%) had Power Doppler grade 1 at joints, 56.4% had calcifications and 30.4% bursitis at enthesis. Sixty patients completed the study. After a median of 76.60 months (IQR 39.34\u201385.25), 34 patients (56.6%) developed MSK symptoms. They had higher BMI (P = 0.013), abdominal circumference (P = 0.022), scored higher for pain (P = 0.047) and fatigue (P = 0.011). Their baseline US showed a higher total US score (P = 0.037). Five patients (8.3%) developed MSK inflammatory symptoms, and four met CASPAR criteria (5.5%). The mean time from baseline to PsA diagnosis was 20.20 months (SD \u00b1 12.02). US bursitis was present in 80% of patients developing inflammatory symptoms (P = 0.049).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a cohort of patients with mild PsO, systemic therapy-naive and no MSK symptoms, incidence of PsA was 1% per year. US bursitis at enthesis was related to the development of symptoms suggestive of PsA. Patients who developed MSK symptoms had higher BMI, fatigue and pain VAS scores at baseline and could constitute a subgroup with higher risk for transition to PsA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf307","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:33:45Z","timestamp":1748936025000},"page":"5396-5403","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicentre study"],"prefix":"10.1093","volume":"64","author":[{"given":"Ana Bel\u00e9n","family":"Azuaga","sequence":"first","affiliation":[{"name":"Rheumatology Department, Hospital Clinic , Barcelona,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cuervo","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital General de Granollers , Granollers,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Reina","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Mois\u00e8s Broggi , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9827-5680","authenticated-orcid":false,"given":"Paula","family":"Estrada-Alarc\u00f3n","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Mois\u00e8s Broggi , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Mateo","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Germans Trias i Pujol , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Aparicio","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Germans Trias i Pujol , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Moreno","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Parc Taul\u00ed , Sabadell,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ar\u00e9valo","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Parc Taul\u00ed , Sabadell,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"L\u00e1iz","sequence":"additional","affiliation":[{"name":"Functional Unit of Systemic Autoimmune Diseases (UFMAS), Rheumatology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB Sant Pau), Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Moya","sequence":"additional","affiliation":[{"name":"Functional Unit of Systemic Autoimmune Diseases (UFMAS), Rheumatology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB Sant Pau), Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3722-9486","authenticated-orcid":false,"given":"Luc\u00eda","family":"Alascio","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Clinic , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Riera","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Clinic , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-6994","authenticated-orcid":false,"given":"Jos\u00e9 U","family":"Scher","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, NYU Grossman School of Medicine , New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7932-2632","authenticated-orcid":false,"given":"Juan D","family":"Ca\u00f1ete","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Clinic , Barcelona,","place":["Spain"]},{"name":"Fundaci\u00f3 Clinic de Recerca Biom\u00e8dica and IDIBAPS , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7047-8056","authenticated-orcid":false,"given":"Julio","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Clinic , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"2025111023563110600_keaf307-B1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.amepre.2014.02.012","article-title":"Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys","volume":"47","author":"Helmick","year":"2014","journal-title":"Am J Prev Med"},{"key":"2025111023563110600_keaf307-B2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"2025111023563110600_keaf307-B3","doi-asserted-by":"crossref","first-page":"i71","DOI":"10.1136\/ard.2010.144097","article-title":"The early phase of psoriatic arthritis","volume":"70","author":"McGonagle","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"2025111023563110600_keaf307-B4","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/bjd.13272","article-title":"Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis","volume":"171","author":"Langenbruch","year":"2014","journal-title":"Br J Dermatol"},{"key":"2025111023563110600_keaf307-B6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/BOR.0000000000000155","article-title":"Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis","volume":"27","author":"Siegel","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"2025111023563110600_keaf307-B7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/rheumatology\/kes324","article-title":"Prevalence and treatment patterns of psoriatic arthritis in the UK","volume":"52","author":"Ogdie","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2025111023563110600_keaf307-B8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2012-201706","article-title":"High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires","volume":"72","author":"Haroon","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2025111023563110600_keaf307-B10","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1136\/annrheumdis-2015-208821","article-title":"Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis","volume":"75","author":"Faustini","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B11","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s13555-023-01025-8","article-title":"Prevalence of musculoskeletal symptoms in patients with psoriasis and predictors associated with the development of psoriatic arthritis: retrospective analysis of a US claims database","volume":"13","author":"Merola","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025111023563110600_keaf307-B12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13075-021-02628-2","article-title":"Longitudinal analysis of the patient pathways to diagnosis of psoriatic arthritis","volume":"23","author":"Ogdie","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025111023563110600_keaf307-B13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025111023563110600_keaf307-B14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10654-018-0366-z","article-title":"Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose\u2013response meta-analysis of prospective studies","volume":"33","author":"Aune","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"2025111023563110600_keaf307-B15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/rheumatology\/kes242","article-title":"Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management","volume":"52","author":"Russolillo","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2025111023563110600_keaf307-B16","first-page":"2577","article-title":"Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire","volume":"29","author":"Alenius","year":"2002","journal-title":"J Rheumatol"},{"key":"2025111023563110600_keaf307-B17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2007.04.001","article-title":"The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool","volume":"57","author":"Husni","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"2025111023563110600_keaf307-B18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/ard.2008.089441","article-title":"Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS)","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B19","first-page":"469","author":"Ibrahim","year":"2009"},{"key":"2025111023563110600_keaf307-B20","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","article-title":"A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative","volume":"73","author":"Gossec","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3899\/jrheum.201199","article-title":"Diagnostic Delay in Psoriatic Arthritis: a Population-based Study","volume":"48","author":"Karmacharya","year":"2021","journal-title":"J Rheumatol"},{"key":"2025111023563110600_keaf307-B23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41927-019-0102-7","article-title":"Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States","volume":"4","author":"Ogdie","year":"2020","journal-title":"BMC Rheumatol"},{"key":"2025111023563110600_keaf307-B24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3899\/jrheum.180195","article-title":"Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set","volume":"46","author":"Elmamoun","year":"2019","journal-title":"J Rheumatol"},{"key":"2025111023563110600_keaf307-B25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40744-021-00420-x","article-title":"Usage of C-reactive protein testing in the diagnosis and monitoring of psoriatic arthritis (PsA): results from a real-world survey in the USA and Europe","volume":"9","author":"Ogdie","year":"2022","journal-title":"Rheumatol Ther"},{"key":"2025111023563110600_keaf307-B26","doi-asserted-by":"crossref","first-page":"723944","DOI":"10.3389\/fmed.2021.723944","article-title":"Early origins of psoriatic arthritis: clinical, genetic and molecular biomarkers of progression from psoriasis to psoriatic arthritis","volume":"8","author":"Pennington","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2025111023563110600_keaf307-B27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/ard.2007.075101","article-title":"Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study","volume":"67","author":"Gisondi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B28","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/rheumatology\/ker078","article-title":"High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study","volume":"50","author":"Naredo","year":"2011","journal-title":"Rheumatology"},{"key":"2025111023563110600_keaf307-B29","first-page":"593","author":"Zuliani","year":"2019"},{"key":"2025111023563110600_keaf307-B30","doi-asserted-by":"crossref","first-page":"e001067","DOI":"10.1136\/rmdopen-2019-001067","article-title":"Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia","volume":"5","author":"Zabotti","year":"2019","journal-title":"RMD Open"},{"key":"2025111023563110600_keaf307-B31","author":"Wakefield","year":"2005"},{"key":"2025111023563110600_keaf307-B32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.10877","article-title":"Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis","volume":"48","author":"Szkudlarek","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025111023563110600_keaf307-B33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/ard.2007.084251","article-title":"Validity of enthesis ultrasound assessment in spondyloarthropathy","volume":"68","author":"de Miguel","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.41239","article-title":"Association of structural entheseal lesions with an increased risk of progression from psoriasis to psoriatic arthritis","volume":"74","author":"Simon","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025111023563110600_keaf307-B35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/art.39494","article-title":"The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study","volume":"68","author":"Eder","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025111023563110600_keaf307-B36","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004314","article-title":"Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage","volume":"10","author":"Zabotti","year":"2024","journal-title":"RMD Open"},{"key":"2025111023563110600_keaf307-B37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/annrheumdis-2021-219961","article-title":"Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis","volume":"81","author":"Gisondi","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/annrheumdis-2021-220865","article-title":"Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis","volume":"81","author":"Acosta Felquer","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/annrheumdis-2021-220761","article-title":"Does biologic therapy impact the development of PsA among patients with psoriasis?","volume":"81","author":"Meer","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025111023563110600_keaf307-B40","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/art.39973","article-title":"The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study","volume":"69","author":"Eder","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025111023563110600_keaf307-B41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.semarthrit.2010.05.009","article-title":"Subclinical entheseal involvement in patients with psoriasis: an ultrasound study","volume":"40","author":"Gutierrez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"2025111023563110600_keaf307-B42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13555-021-00663-0","article-title":"Development of a predictive model for screening patients with psoriasis at increased risk of psoriatic arthritis","volume":"12","author":"Wang","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025111023563110600_keaf307-B43","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4103\/idoj.IDOJ_446_18","article-title":"Sonographic evaluation of subclinical enthesopathy in patients of chronic plaque psoriasis","volume":"11","author":"Vyas","year":"2020","journal-title":"Indian Dermatol Online J"},{"issue":"Suppl 1","key":"2025111023563110600_keaf307-B44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2009.03363.x","article-title":"Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease","volume":"23","author":"McGonagle","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025111023563110600_keaf307-B45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jbspin.2015.01.016","article-title":"Ultrasound study of entheses in psoriasis patients with or without musculoskeletal symptoms: a prospective study","volume":"82","author":"Acquacalda","year":"2015","journal-title":"Joint Bone Spine"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf307\/63436263\/keaf307.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/10\/5396\/63436263\/keaf307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/10\/5396\/63436263\/keaf307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:56:42Z","timestamp":1762837002000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/10\/5396\/8156778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,6,4]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf307","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,6,4]]}}}